Canaccord Genuity Reiterates a 'Buy' on Triangle Petroleum (TPLM); Catalysts on the Horizon
Tweet
Share
E-mailGet Alerts TPLM Hot Sheet
Price: $0.01 --0%
Rating Summary:
3 Buy, 9 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 4 | Down: 12 | New: 7
Rating Summary:
3 Buy, 9 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 4 | Down: 12 | New: 7
Join SI Premium – FREE
Canaccord Genuity reiterates a 'Buy' on Triangle Petroleum (NYSE: TPLM) price target raised to $10.00.
Analyst, Marcus Talbert, said, "We are reiterating our rating and raising our target price following insights we picked up during our recent marketing event with management. Triangle Petroleum remains our favorite Bakken idea based on its leading leverage to the play and meaningful near- to mid-term catalysts. We continue to believe TPLM remains too cheap for a company with its asset base, liquidity and relative growth potential. In our view, project execution is the key catalyst for outperformance in ‘12."
For an analyst ratings summary and ratings history on Triangle Petroleum click here. For more ratings news on Triangle Petroleum click here.
Shares of Triangle Petroleum closed at $0.69 yesterday.
Analyst, Marcus Talbert, said, "We are reiterating our rating and raising our target price following insights we picked up during our recent marketing event with management. Triangle Petroleum remains our favorite Bakken idea based on its leading leverage to the play and meaningful near- to mid-term catalysts. We continue to believe TPLM remains too cheap for a company with its asset base, liquidity and relative growth potential. In our view, project execution is the key catalyst for outperformance in ‘12."
For an analyst ratings summary and ratings history on Triangle Petroleum click here. For more ratings news on Triangle Petroleum click here.
Shares of Triangle Petroleum closed at $0.69 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Goldman Sachs Downgrades Vibra Energia SA (VBBR3:BZ) to Neutral
- Wolfe Research Starts Harmony Biosciences Holdings Inc. (HRMY) at Outperform
- JPMorgan Upgrades XPeng (H-Shares) (9868:HK) (XPEV) to Overweight
Create E-mail Alert Related Categories
Analyst Comments, Analyst PT ChangeRelated Entities
Bakken FormationSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
